claim: single-cell omics reveals dyssynchrony of the innate and adaptive immune system in progressive covid-19
evidence_1: here, we utilize multiomics single-cell analysis to probe dynamic immune responses in patients with stable or progressive manifestations of covid-19, and assess the effects of tocilizumab, an anti-il-6 receptor monoclonal antibody.